Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.
about
Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literatureMagnetic resonance safety.Nephrogenic systemic fibrosis in liver disease: a systematic review.Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update.A case of delayed onset nephrogenic systemic fibrosis after gadolinium based contrast injection.Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.Simultaneous magnetic resonance angiography and perfusion (MRAP) measurement: initial application in lower extremity skeletal muscleDecreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.Gadolinium and nephrogenic systemic fibrosis: association or causation.Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed casesUnderstanding nephrogenic systemic fibrosisNephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis.Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide.Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis
P2860
Q24548184-2658F99C-BDE0-4C2A-80E3-20972338AB62Q30362015-C3671B9D-20C9-4B51-82CC-ED6EC04736EEQ33748364-B2CC40E3-57C6-4F69-8169-1C8D50827923Q34223200-82D53192-79E6-4C1B-96F4-97BAD9545C46Q36059081-6B245282-0B6E-4FB1-B0FC-FA085CB341E3Q36148570-F9EE37A5-4245-4140-820B-1B75F75EB263Q36509315-E56C3273-FE39-48BD-9CBB-0F0663829495Q36536716-68093DB2-F093-4AEB-94BB-9337D9218AFFQ36808088-6D00D0E9-8D47-4193-B0C4-94F6243C6EBBQ36854305-B91380E0-1AC4-437A-88D1-4062D909CABCQ36974375-ED796AD0-0241-4EFB-BE84-4121DF9ECEC0Q37067538-FCB42CF1-88FF-4D6E-ABCD-4AEE18D53273Q37271690-C7C26B2E-EF35-49D1-A7E6-C752042AAAB3Q37875688-2EF45E61-6130-43A8-8DE8-A35D343B2B12Q41545279-872AF3EF-2628-471C-9574-B7A21C2741EBQ41942016-AA35AF1F-63AF-40CF-ADDE-248429F8A6F9Q43117154-7BD28DB5-6039-45B0-9063-0B78FADBB6CFQ58993973-33305354-5CE3-4870-8A31-AD011C18B00A
P2860
Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@ast
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@en
type
label
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@ast
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@en
prefLabel
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@ast
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@en
P2093
P356
P1476
Nephrogenic fibrosing dermopat ...... n patients with renal failure.
@en
P2093
Dirk Kuypers
Kathleen Claes
Miranda Zeegers
Patrick Flamen
Pieter Evenepoel
Sabine Fransis
Siegfried Segaert
Yves Vanrenterghem
P304
P356
10.1093/NDT/GFG506
P407
P577
2004-02-01T00:00:00Z